LG LGP990HN User Guide - Page 25

radiofrequency energy RF. The FDA

Page 25 highlights

However, none of the studies can answer questions about longterm exposures, since the average period of phone use in these studies was around three years. 5. What research is needed to decide whether RF exposure from wireless phones poses a health risk? A combination of laboratory studies and epidemiological studies of people actually using wireless phones would provide some of the data that are needed. Lifetime animal exposure studies could be completed in a few years. However, very large numbers of animals would be needed to provide reliable proof of a cancer promoting effect if one exists. Epidemiological studies can provide data that is directly applicable to human populations, but 10 or more years follow-up may be needed to provide answers about some health effects, such as cancer. This is because the interval between the time of exposure to a cancercausing agent and the time tumors develop - if they do may be many, many years. The interpretation of epidemiological studies is hampered by difficulties in measuring actual RF exposure during day-to-day use of wireless phones. Many factors affect this measurement, such as the angle at which the phone is held, or which model of phone is used. 6. What is the FDA doing to find out more about the possible health effects of wireless phone RF? The FDA is working with the U.S. National Toxicology Program and with groups of investigators around the world to ensure that high priority animal studies are conducted to address important questions about the effects of exposure to radiofrequency energy (RF). The FDA has been a leading participant in the 23

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118

23
However, none of the studies can
answer questions about longterm
exposures, since the average period
of phone use in these studies was
around three years.
5.
What research is needed to
decide whether RF exposure
from wireless phones poses a
health risk?
A combination of laboratory studies
and epidemiological studies of
people actually using wireless
phones would provide some of
the data that are needed. Lifetime
animal exposure studies could be
completed in a few years. However,
very large numbers of animals
would be needed to provide reliable
proof of a cancer promoting effect if
one exists. Epidemiological studies
can provide data that is directly
applicable to human populations, but
10 or more years follow-up may be
needed to provide answers about
some health effects, such as cancer.
This is because the interval between
the time of exposure to a cancer-
causing agent and the time tumors
develop - if they do may be many,
many years. The interpretation of
epidemiological studies is hampered
by difficulties in measuring actual RF
exposure during day-to-day use of
wireless phones. Many factors affect
this measurement, such as the angle
at which the phone is held, or which
model of phone is used.
6.
What is the FDA doing to find
out more about the possible
health effects of wireless
phone RF?
The FDA is working with the U.S.
National Toxicology Program and
with groups of investigators around
the world to ensure that high priority
animal studies are conducted
to address important questions
about the effects of exposure to
radiofrequency energy (RF). The FDA
has been a leading participant in the